REPEATED ECS DIFFERENTIALLY AFFECTS RAT-BRAIN 5-HT1A AND 5-HT2A RECEPTOR EXPRESSION

被引:55
作者
BURNET, PWJ
MEAD, A
EASTWOOD, SL
LACEY, K
HARRISON, PJ
SHARP, T
机构
[1] UNIV OXFORD, RADCLIFFE INFIRM, DEPT NEUROPATHOL, OXFORD OX2 6HE, ENGLAND
[2] UNIV OXFORD, RADCLIFFE INFIRM, DEPT CLIN PHARMACOL, OXFORD OX2 6HE, ENGLAND
基金
英国惠康基金;
关键词
5-HT1A; 5-HT2A; HIPPOCAMPUS; ELECTROCONVULSIVE SHOCK; SEIZURE; MESSENGER-RNA; IN SITU HYBRIDIZATION; ANTIDEPRESSANT;
D O I
10.1097/00001756-199504190-00019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
WE investigated the effect of electroconvulsive shock (ECS), administered five times over 10 days, on 5-HT1A and 5-HT2A receptor mRNA and binding site densities in the rat brain using in situ hybridization histochemistry and quantitative autoradiography. ECS treatment increased 5-HT1A receptor mRNA abundance and binding site densities in the dentate gyrus, but decreased these parameters in the CA3c layer of the hippocampus. No changes in 5-HT1A receptor mRNA and binding sites occurred in other hippocampal subfields, neocortex or raphe nuclei. Repeated ECS was also found to increase 5-HT2A receptor binding site densities in the neocortex and this was accompanied by a non-significant increase in cortical 5-HT2A receptor mRNA abundance. Our study demonstrates that in the rat, repeated ECS produces anatomically and molecularly discrete effects on 5-HT1A and 5-HT2A receptor gene expression. These changes may be relevant to the therapeutic effect of repeated ECS in depression.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 24 条
[1]  
Pearlman C., Gen Hosp Psychiatry, 13, pp. 128-137, (1991)
[2]  
Goodwin G.M., De Souza R.J., Green A.R., Psychopharmacology, 91, pp. 500-505, (1987)
[3]  
Goodwin G.M., De Souza R.J., Green A.R., Neuropharmacology, 24, pp. 1187-1194, (1985)
[4]  
Gartside S.E., Ellis P.M., Sharp T., Et al., Eur J Pharmacol, 221, pp. 27-33, (1992)
[5]  
Green A.R., Johnson P., Nimgaonkar V.L., Br J Pharmacol, 80, pp. 173-177, (1983)
[6]  
Pandey S.C., Isaac L., Davis J.M., Et al., Eur J Pharmacol, 202, pp. 221-225, (1991)
[7]  
Hayakawa H., Shimizu M., Nishida A., Et al., Neuropsychobiology, 30, pp. 53-56, (1994)
[8]  
Keller K.J., Cascio C.S., Butler J.A., Et al., Eur J Pharmacol, 69, pp. 515-518, (1981)
[9]  
Biegon A., Israeli M., J Neurochem, 48, pp. 1386-1391, (1987)
[10]  
Mikkelsen J.D., Woldbye D., Kragh J., Et al., Mol Brain Res, 23, pp. 317-322, (1994)